DD116239A5 - - Google Patents

Info

Publication number
DD116239A5
DD116239A5 DD183614A DD18361475A DD116239A5 DD 116239 A5 DD116239 A5 DD 116239A5 DD 183614 A DD183614 A DD 183614A DD 18361475 A DD18361475 A DD 18361475A DD 116239 A5 DD116239 A5 DD 116239A5
Authority
DD
German Democratic Republic
Application number
DD183614A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD116239A5 publication Critical patent/DD116239A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DD183614A 1974-01-14 1975-01-13 DD116239A5 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (cg-RX-API-DMAC7.html) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
DD116239A5 true DD116239A5 (cg-RX-API-DMAC7.html) 1975-11-12

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
DD183614A DD116239A5 (cg-RX-API-DMAC7.html) 1974-01-14 1975-01-13

Country Status (27)

Country Link
JP (2) JPS58407B2 (cg-RX-API-DMAC7.html)
AT (1) AT345449B (cg-RX-API-DMAC7.html)
AU (1) AU500250B2 (cg-RX-API-DMAC7.html)
BE (1) BE824372A (cg-RX-API-DMAC7.html)
CA (1) CA1049406A (cg-RX-API-DMAC7.html)
CH (1) CH589453A5 (cg-RX-API-DMAC7.html)
CS (1) CS191254B2 (cg-RX-API-DMAC7.html)
DD (1) DD116239A5 (cg-RX-API-DMAC7.html)
DE (1) DE2500785B2 (cg-RX-API-DMAC7.html)
DK (1) DK140003B (cg-RX-API-DMAC7.html)
ES (1) ES433759A1 (cg-RX-API-DMAC7.html)
FI (1) FI54053C (cg-RX-API-DMAC7.html)
FR (1) FR2257305B1 (cg-RX-API-DMAC7.html)
GB (1) GB1498261A (cg-RX-API-DMAC7.html)
HK (1) HK56380A (cg-RX-API-DMAC7.html)
HU (1) HU173920B (cg-RX-API-DMAC7.html)
IE (1) IE40794B1 (cg-RX-API-DMAC7.html)
IL (1) IL46426A (cg-RX-API-DMAC7.html)
MY (1) MY8100204A (cg-RX-API-DMAC7.html)
NL (1) NL166622C (cg-RX-API-DMAC7.html)
NO (1) NO143128C (cg-RX-API-DMAC7.html)
PH (1) PH14458A (cg-RX-API-DMAC7.html)
PL (1) PL93689B1 (cg-RX-API-DMAC7.html)
SE (1) SE427238B (cg-RX-API-DMAC7.html)
SU (1) SU616997A3 (cg-RX-API-DMAC7.html)
YU (1) YU41289B (cg-RX-API-DMAC7.html)
ZA (1) ZA75259B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ATE494906T1 (de) * 2005-11-01 2011-01-15 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
JP5535910B2 (ja) * 2007-08-28 2014-07-02 バクスター・インターナショナル・インコーポレイテッド ウイルスワクチンを生産する方法
CA2930634C (en) 2013-11-15 2023-05-09 Novartis Ag Removal of influenza nuclear protein (np) from influenza virus preparations

Also Published As

Publication number Publication date
NO750031L (cg-RX-API-DMAC7.html) 1975-08-11
JPS50100224A (cg-RX-API-DMAC7.html) 1975-08-08
ATA21475A (de) 1978-01-15
DK140003C (cg-RX-API-DMAC7.html) 1979-10-29
NL7500301A (nl) 1975-07-16
YU5875A (en) 1984-04-30
CA1049406A (en) 1979-02-27
CS191254B2 (en) 1979-06-29
FI750014A7 (cg-RX-API-DMAC7.html) 1975-07-15
HU173920B (hu) 1979-09-28
DE2500785B2 (de) 1980-01-03
IL46426A0 (en) 1975-04-25
JPS58407B2 (ja) 1983-01-06
IL46426A (en) 1978-01-31
BE824372A (fr) 1975-07-14
SE427238B (sv) 1983-03-21
NL166622B (nl) 1981-04-15
NO143128B (no) 1980-09-15
FR2257305A1 (cg-RX-API-DMAC7.html) 1975-08-08
SU616997A3 (ru) 1978-07-25
JPS6035326B2 (ja) 1985-08-14
AT345449B (de) 1978-09-11
DE2500785C3 (cg-RX-API-DMAC7.html) 1980-09-11
MY8100204A (en) 1981-12-31
CH589453A5 (cg-RX-API-DMAC7.html) 1977-07-15
HK56380A (en) 1980-10-16
IE40794L (en) 1975-07-14
PL93689B1 (cg-RX-API-DMAC7.html) 1977-06-30
NO143128C (no) 1980-12-29
DE2500785A1 (de) 1975-07-31
IE40794B1 (en) 1979-08-15
FI54053B (fi) 1978-06-30
ZA75259B (en) 1976-08-25
FR2257305B1 (cg-RX-API-DMAC7.html) 1982-03-19
DK140003B (da) 1979-06-05
SE7500130L (cg-RX-API-DMAC7.html) 1975-07-15
PH14458A (en) 1981-07-29
JPS56127319A (en) 1981-10-06
NL166622C (nl) 1981-09-15
AU7730575A (en) 1976-07-15
FI54053C (fi) 1978-10-10
AU500250B2 (en) 1979-05-17
DK1475A (cg-RX-API-DMAC7.html) 1975-09-01
YU41289B (en) 1987-02-28
GB1498261A (en) 1978-01-18
ES433759A1 (es) 1977-02-16

Similar Documents

Publication Publication Date Title
FR2261587B1 (cg-RX-API-DMAC7.html)
DK141761C (cg-RX-API-DMAC7.html)
DK140003C (cg-RX-API-DMAC7.html)
FR2278717B1 (cg-RX-API-DMAC7.html)
BG21462A1 (cg-RX-API-DMAC7.html)
BG19896A1 (cg-RX-API-DMAC7.html)
CH588371A5 (cg-RX-API-DMAC7.html)
CH565976A5 (cg-RX-API-DMAC7.html)
CH584385A5 (cg-RX-API-DMAC7.html)
CH577203B5 (cg-RX-API-DMAC7.html)
CH575486A5 (cg-RX-API-DMAC7.html)
CH588255A5 (cg-RX-API-DMAC7.html)
CH595699A5 (cg-RX-API-DMAC7.html)
BG20224A1 (cg-RX-API-DMAC7.html)
CH590125A5 (cg-RX-API-DMAC7.html)
CH587083A5 (cg-RX-API-DMAC7.html)
CH567726A5 (cg-RX-API-DMAC7.html)
CH576898A5 (cg-RX-API-DMAC7.html)
CH579267A5 (cg-RX-API-DMAC7.html)
BG21760A1 (cg-RX-API-DMAC7.html)
CH576200A5 (cg-RX-API-DMAC7.html)
CH572155A5 (cg-RX-API-DMAC7.html)
BG19628A1 (cg-RX-API-DMAC7.html)
CH580011A5 (cg-RX-API-DMAC7.html)
CH577252A5 (cg-RX-API-DMAC7.html)